These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2138994

  • 1. High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia.
    Lie SO, Berglund G, Gustafsson G, Jonmundsson G, Siimes M, Yssing M.
    Haematol Blood Transfus; 1990; 33():215-21. PubMed ID: 2138994
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemia.
    Jehn U, Heinemann V.
    Haematol Blood Transfus; 1990; 33():333-8. PubMed ID: 1691134
    [Abstract] [Full Text] [Related]

  • 6. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
    Ritter J, Creutzig U, Schellong G.
    Haematol Blood Transfus; 1990; 33():185-92. PubMed ID: 2182410
    [No Abstract] [Full Text] [Related]

  • 7. Therapy of childhood acute myelogenous leukemia: an update of the AIEOP/LAM 8204 study. Italian Pediatric Hematology-Oncology Association.
    Amadori S, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Vegna ML, Moleti ML.
    Haematol Blood Transfus; 1990; 33():222-5. PubMed ID: 2182413
    [No Abstract] [Full Text] [Related]

  • 8. Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia.
    Kurrle E, Ehninger G, Fackler-Schwalbe E, Freund M, Heil G, Hoelzer D, Link H, Löffler B, Lösch A, Mitrou PS.
    Haematol Blood Transfus; 1990; 33():254-60. PubMed ID: 2182418
    [No Abstract] [Full Text] [Related]

  • 9. Remission induction and postremission therapy in acute myelogenous leukemia: British MRC Study.
    Rees JK, Gray RG.
    Haematol Blood Transfus; 1990; 33():243-8. PubMed ID: 1691131
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
    Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y, Kodera Y, Saito H.
    Haematol Blood Transfus; 1990; 33():304-8. PubMed ID: 2182424
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapy of acute myelogenous leukemia in adults.
    Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A.
    Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
    [No Abstract] [Full Text] [Related]

  • 14. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
    Lampkin BC, Woods WG, Buckley JD, Hammond GD.
    Haematol Blood Transfus; 1990; 33():210-4. PubMed ID: 1691130
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
    Petti MC, Mandelli F, Vegna ML, Broccia G, Carotenuto M, De Rosa F, Di Marco P, Di Raimondo F, Fioritoni G, Leone G.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
    [No Abstract] [Full Text] [Related]

  • 17. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S, Testi AM, Aricò M, Comelli A, Giuliano M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F.
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [Abstract] [Full Text] [Related]

  • 18. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
    Büchner T, Hiddemann W, Blasius S, Koch P, Maschmeyer G, Tirier C, Sodomann H, Kuse R, Thiel E, Ludwig WD.
    Haematol Blood Transfus; 1990 Jun; 33():261-6. PubMed ID: 2182419
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.